James Chopas - Sep 14, 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
VP/Chief Accounting Officer
Signature
/s/ David Watson, attorney-in-fact for James Chopas
Stock symbol
APLS
Transactions as of
Sep 14, 2023
Transactions value $
$0
Form type
4
Date filed
9/18/2023, 04:20 PM
Previous filing
Sep 1, 2023
Next filing
Oct 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Award $0 +2.5K +8.25% $0.00 32.8K Sep 14, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents a Restricted Stock Unit award granted 09/14/23 that vest 25% every 6 months from grant date over a two year period subject to continued service.